HK inno.N Corp.

Industry

  • Biotechnology
    • Gene Therapy, Cell Therapy
    • Large Molecule
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
    • Drug Delivery
    • Nutraceuticals
    • OTC, Consumer
    • Vaccines
  • Contract Manufacturing Organization

Other Names/Subsidiaries

  • CJ HealthCare Corp.
See more in Biomedtracker

Latest on HK inno.N Corp.

Scrip

Navigator Medicines Emerges With $100m, Autoimmune Candidate

 
• By Joseph Haas

Navigator Medicines unveiled its plans to develop novel medicines for complex, heterogeneous autoimmune diseases on 27 August, revealing that it has raised $100m in series A funding from RA Capital M

Scrip

Asia Deal Watch: ProGen To Partner With Rani On GLP-2 Agonist In Obesity

 
• By Joseph Haas, Jung Won Shin, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. ProGen Partners With Rani To Devel

Scrip

Deal Watch: AbbVie Pursues Novel Neuropsychiatric Drug Class With Gilgamesh

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Gilgamesh To Investigate Potent

Scrip

Korea Q4 Roundup: International Growth A Key Factor For Major Firms

 
• By Jung Won Shin

Several major South Korean pharma companies reported strong earnings in the fourth quarter and for the whole of 2022, led by in-house developed or other key prescription drugs, as well as growing over